Bicuspid Aortic Valves (VAV) are challenging for TAVR given its anatomical characteristics and the important presence of calcification. However, current data are promising. Even though traditionally excluded from the larger randomized studies, self-expandable valves appear to have similar evolution to tricuspid aortic valves (TAV) with severe stenosis. Researchers looked at the Low-Risk Bicuspid Study and...
Are Expandable-Balloon Valves an Option for the Bicuspid Valve in Low-Risk Patients?
Bicuspid aortic valve malformation is the most frequent cardiac malformation (about 1%), and a significant percentage of these cases generate severe aortic stenosis. As we know, transcatheter aortic valve replacement (TAVR) has been developed for tricuspid valves, which are studied in the most important randomized trials for high-, medium-, and low-risk patients. While current information...
Is Cusp Overlapping Projection the New Self-Expandable Valve Implantation Technique?
In Europe and the US, aortic stenosis is the most frequent cause of valve intervention, both surgical and percutaneous, and, as we all know, TAVR has made great progress in this regard. However, this technique has an Achilles heel when it comes to self-expandable valves: definite pacemaker implantation rate is 3 to 4 times higher...
08/03 | LATAM Network of Interventional Women: 4 Simultaneous Educational Activities!
SOLACI and the Latin American Interventional Women Group (Grupo MIL) continue to promote continuing medical education, in this case with four simultaneous activities organized with Medtronic and aimed at female interventional specialists. In this one-of-a-kind session, participants will have the opportunity to discuss clinical data and procedural techniques with experts. The event will be held on...
Minimizing One of Our Major Procedures to a Minimum
In some cases, full atrioventricular (AV) block occurs beyond two days after transcatheter aortic valve replacement (TAVR). This highlights the usefulness of extending monitoring after discharge, particularly in patients who tolerated the procedure well, but meet high-risk criteria. We have made great progress regarding conduction disorders in TAVR, especially after the publication of the consensus...
The Most Relevant Articles of 2021 in Pharmacology
This last year, new data in pharmacology gave way to changes in practices and new hypotheses, when not simply further justified the already existing evidence. In this new editorial section, we share the most relevant of last year’s works to keep you up to speed on the main topics in the field. The Most Relevant...
The Most Relevant of 2021 In Structural Heart Disease
This last year, new data in structural heart disease gave way to changes in practices and new hypotheses, when not simply further justified the already existing evidence. In this new editorial section, we share the most relevant of last year’s works to keep you up to speed on the main topics in the field. The...
SOLACI’s Year
2021 was filled with challenges for SOLACI. Many of the initiatives we started planning in 2020 saw the light and became a reality that strengthens our society’s reach and mission. And not just that: we have also stepped up our efforts to expand and develop our traditional institutional activities always with the intent to add...
The Most Read Articles of 2021: Pharmacology
A new year is coming to an end and at SOLACI we are going over the most read studies on our website, on a vital topic, pharmacology. Follow us to keep up to date. The Most Read Articles of 2021: Pharmacology 01- Swan Ganz Associated with Better Outcomes in Cardiogenic Shock: Is It Back? The Swan...
The Most Read Articles of 2021: Structural Heart Disease
A new year is coming to an end and at SOLACI we are going over the most read studies on our website, on a vital topic, peripheral vascular disease. Follow us to keep up to date. The Most Read Articles of 2021: Structural Heart Disease 01- Surgeons’ Claim on Low-Risk Patients with Aortic Stenosis Recent...